|
1GA5
CRYSTAL STRUCTURE OF THE ORPHAN NUCLEAR RECEPTOR REV-ERB(ALPHA) DNA-BINDING DOMAIN BOUND TO ITS COGNATE RESPONSE ELEMENT
Deposited 2000-11-29
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Homooligomer;Protein × 2
PDB declaration: tetrameric
|
Chain A
123–216(94 aa)
Fragment:DNA-BINDING DOMAIN PLUS C-TERMINAL EXTENSION
Chain B
123–216(94 aa)
Fragment:DNA-BINDING DOMAIN PLUS C-TERMINAL EXTENSION
|
Not recorded
|
ZN ZINC ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;290 K;25% PEG8000, 5mM MgCl2, 400 mM NaCl, Tris, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 290K
|
Resolution 2.40 Å
R-free 0.299
|
|
1GA5
CRYSTAL STRUCTURE OF THE ORPHAN NUCLEAR RECEPTOR REV-ERB(ALPHA) DNA-BINDING DOMAIN BOUND TO ITS COGNATE RESPONSE ELEMENT
Deposited 2000-11-29
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–DNA
Homooligomer;Protein × 2
PDB declaration: tetrameric
|
Chain E
123–216(94 aa)
Fragment:DNA-BINDING DOMAIN PLUS C-TERMINAL EXTENSION
Chain F
123–216(94 aa)
Fragment:DNA-BINDING DOMAIN PLUS C-TERMINAL EXTENSION
|
Not recorded
|
ZN ZINC ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;290 K;25% PEG8000, 5mM MgCl2, 400 mM NaCl, Tris, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 290K
|
Resolution 2.40 Å
R-free 0.299
|
|
1HLZ
CRYSTAL STRUCTURE OF THE ORPHAN NUCLEAR RECEPTOR REV-ERB(ALPHA) DNA-BINDING DOMAIN BOUND TO ITS COGNATE RESPONSE ELEMENT
Deposited 2000-12-04
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Homooligomer;Protein × 2
PDB declaration: tetrameric
|
Chain A
123–216(94 aa)
Fragment:DNA-BINDING DOMAIN PLUS C-TERMINAL EXTENSION
Chain B
123–216(94 aa)
Fragment:DNA-BINDING DOMAIN PLUS C-TERMINAL EXTENSION
|
Not recorded
|
ZN ZINC ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;290 K;25% PEG8000, 5 mM MgCl2, 400 mM NaCl, Tris buffer, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 290K
|
Resolution 2.80 Å
R-free 0.310
|
|
3N00
Crystal Structure of a deletion mutant of human Reverba ligand binding domain bound with an NCoR ID1 peptide determined to 2.60A
Deposited 2010-05-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
281–323(43 aa)
Chain A
423–614(192 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.5;295 K;1ul of precipitant composed of 6-9% of PEG 3350, 8% glycerol, 200mM proline, 80mM HEPES was mixed with 1uL of the Rev-erba NCoR complex at 5-6 mG/Lit to obtain diffraction grade crystals, pH 7.5, VAPOR DIFFUSION, temperature 295K
|
Resolution 2.60 Å
R-free 0.266
|
|
3N00
Crystal Structure of a deletion mutant of human Reverba ligand binding domain bound with an NCoR ID1 peptide determined to 2.60A
Deposited 2010-05-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
281–323(43 aa)
Chain A
423–614(192 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.5;295 K;1ul of precipitant composed of 6-9% of PEG 3350, 8% glycerol, 200mM proline, 80mM HEPES was mixed with 1uL of the Rev-erba NCoR complex at 5-6 mG/Lit to obtain diffraction grade crystals, pH 7.5, VAPOR DIFFUSION, temperature 295K
|
Resolution 2.60 Å
R-free 0.266
|
|
8D8I
Crystal structure of Reverb alpha in complex with synthetic agonist
Deposited 2022-06-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
281–323(43 aa)
Chain A
425–614(190 aa)
|
Not recorded
|
QFX (4S)-6-[([1,1'-biphenyl]-2-yl)oxy]-3-chloro[1,2,4]triazolo[4,3-b]pyridazine × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;295.15 K;80mM Na Hepes pH7.5, 200mM proline, 8% glycerol and 18% PEG3350
|
Resolution 2.50 Å
R-free 0.239
|